US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist

0.5670
-0.0227-3.85%

Close Nov 22 16:00 ET

0.5000
-0.0670-11.82%

Post 20:01 ET

4.59MMarket Cap-78P/E (TTM)

Virpax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Virpax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--
--	2023/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2023/Q40.000 / 0.000--

--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Virpax Pharmaceuticals Earnings Reports

Virpax Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 14 17:07 ET

Virpax Pharmaceuticals | 10-K/A: Annual report (Amendment)

Oct 10 17:11 ET

Virpax Pharmaceuticals | 10-K/A: Annual report (Amendment)

Oct 10 17:10 ET

Virpax Pharmaceuticals | 8-K: VIRPAX PHARMACEUTICALS REPORTS 2024 SECOND QUARTER RESULTS AND RECENT DEVELOPMENTS

Aug 13 07:37 ET

Analyst Rating

Updated: Nov 13, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall